Net Cash Provided by (Used in) Operating Activities |
-193K |
USD |
+83.7% |
Q1 2023 |
Q1 2023 |
Net Cash Provided by (Used in) Financing Activities |
240K |
USD |
-70.4% |
Q1 2023 |
Q1 2023 |
Common Stock, Shares Authorized |
6B |
shares |
0% |
Q3 2023 |
Q3 2023 |
Common Stock, Shares, Issued |
1.6B |
shares |
+0.25% |
Q3 2023 |
Q3 2023 |
Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2023 |
Q3 2023 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
593 |
USD |
|
Q1 2023 |
Q1 2023 |
Deferred Tax Assets, Valuation Allowance |
6.87M |
USD |
+54.2% |
Q3 2023 |
Q3 2023 |
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
0.21 |
pure |
0% |
Q1 2023 |
Q1 2023 |
Deferred Tax Assets, Gross |
6.87M |
USD |
+54.2% |
Q3 2023 |
Q3 2023 |
Preferred Stock, Shares Authorized |
50M |
shares |
0% |
Q3 2023 |
Q3 2023 |
Additional Paid in Capital |
10.5M |
USD |
+0.73% |
Q3 2023 |
Q3 2023 |
Interest Expense |
4.73M |
USD |
-31.2% |
Q3 2023 |
Q3 2023 |
Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2023 |
Q3 2023 |